DL, A., K, M., D, D., SK, W., Y, H., D, B., . . . F, N. (2010). Oral treatment with HE3286 ameliorates disease in rodent models of rheumatoid arthritis. International journal of molecular medicine, 25(4), 625. https://doi.org/10.3892/ijmm_00000385
Chicago Style (17th ed.) CitationDL, Auci, Mangano K, Destiche D, White SK, Huang Y, Boyle D, Frincke J, Reading CL, and Nicoletti F. "Oral Treatment with HE3286 Ameliorates Disease in Rodent Models of Rheumatoid Arthritis." International Journal of Molecular Medicine 25, no. 4 (2010): 625. https://doi.org/10.3892/ijmm_00000385.
MLA (9th ed.) CitationDL, Auci, et al. "Oral Treatment with HE3286 Ameliorates Disease in Rodent Models of Rheumatoid Arthritis." International Journal of Molecular Medicine, vol. 25, no. 4, 2010, p. 625, https://doi.org/10.3892/ijmm_00000385.